La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !
Beijing Tong Ren Tang Chinese Medicine Gestione
Gestione criteri di controllo 0/4
Al momento non disponiamo di informazioni sufficienti sull'amministratore delegato.
Informazioni chiave
Wang Chi
Amministratore delegato
n/a
Compenso totale
| Percentuale dello stipendio del CEO | n/a |
| Mandato del CEO | less than a year |
| Proprietà del CEO | n/a |
| Durata media del management | less than a year |
| Durata media del Consiglio di amministrazione | 2.1yrs |
Aggiornamenti recenti sulla gestione
Recent updates
Earnings Troubles May Signal Larger Issues for Beijing Tong Ren Tang Chinese Medicine (HKG:3613) Shareholders
Sep 06
Is There An Opportunity With Beijing Tong Ren Tang Chinese Medicine Company Limited's (HKG:3613) 31% Undervaluation?
Sep 02Beijing Tong Ren Tang Chinese Medicine Company Limited's (HKG:3613) 28% Share Price Plunge Could Signal Some Risk
Feb 05Calculating The Intrinsic Value Of Beijing Tong Ren Tang Chinese Medicine Company Limited (HKG:3613)
Jan 03A Look At The Intrinsic Value Of Beijing Tong Ren Tang Chinese Medicine Company Limited (HKG:3613)
Sep 28Here's Why We Think Beijing Tong Ren Tang Chinese Medicine (HKG:3613) Might Deserve Your Attention Today
Jul 12Is Now The Time To Put Beijing Tong Ren Tang Chinese Medicine (HKG:3613) On Your Watchlist?
Mar 29Beijing Tong Ren Tang Chinese Medicine (HKG:3613) Has Announced That It Will Be Increasing Its Dividend To HK$0.28
Apr 28Beijing Tong Ren Tang Chinese Medicine (HKG:3613) Will Pay A Larger Dividend Than Last Year At HK$0.28
Mar 25Are Beijing Tong Ren Tang Chinese Medicine Company Limited (HKG:3613) Investors Paying Above The Intrinsic Value?
Oct 27Beijing Tong Ren Tang Chinese Medicine's (HKG:3613) Sluggish Earnings Might Be Just The Beginning Of Its Problems
Apr 28Read This Before Selling Beijing Tong Ren Tang Chinese Medicine Company Limited (HKG:3613) Shares
Mar 11What Type Of Returns Would Beijing Tong Ren Tang Chinese Medicine's(HKG:3613) Shareholders Have Earned If They Purchased Their SharesYear Ago?
Feb 04Should Beijing Tong Ren Tang Chinese Medicine Company Limited (HKG:3613) Be Part Of Your Dividend Portfolio?
Jan 18
Could The Beijing Tong Ren Tang Chinese Medicine Company Limited (HKG:3613) Ownership Structure Tell Us Something Useful?
Dec 29Read This Before Selling Beijing Tong Ren Tang Chinese Medicine Company Limited (HKG:3613) Shares
Dec 11Beijing Tong Ren Tang Chinese Medicine Company Limited's (HKG:3613) Stock's On An Uptrend: Are Strong Financials Guiding The Market?
Nov 23AMMINISTRATORE DELEGATO
Wang Chi (49 yo)
less than a year
Mandato
Mr. Wang Chi is Executive Director and Chief Executive Officer of Beijing Tong Ren Tang Chinese Medicine Company Limited from May 10, 2024. Mr. Chi has experience in Medical and Pharmaceutical industry. Mr...
Gruppo dirigente
| Nome | Posizione | Mandato | Compensazione | Proprietà |
|---|---|---|---|---|
| Executive Chairman of the Board | less than a year | Nessun dato | Nessun dato | |
| Executive Director & Executive Deputy GM | less than a year | HK$975.00k | 0.0073% HK$ 562.0k | |
| CEO & Executive Director | less than a year | Nessun dato | Nessun dato | |
| CFO & Company Secretary | 4.3yrs | Nessun dato | Nessun dato | |
| Deputy GM & General Counsel | no data | Nessun dato | Nessun dato |
0.5yrs
Durata media
50yo
Età media
Gestione esperta: Il team dirigenziale di 3613 non è considerato esperto (durata media 0.5 anni), il che suggerisce un nuovo team.
Membri del Consiglio di amministrazione
| Nome | Posizione | Mandato | Compensazione | Proprietà |
|---|---|---|---|---|
| Executive Chairman of the Board | less than a year | Nessun dato | Nessun dato | |
| Executive Director & Executive Deputy GM | 4.5yrs | HK$975.00k | 0.0073% HK$ 562.0k | |
| CEO & Executive Director | less than a year | Nessun dato | Nessun dato | |
| Independent Non-Executive Director | 7yrs | HK$288.00k | Nessun dato | |
| Independent Non-Executive Director | 11.4yrs | HK$288.00k | Nessun dato | |
| Non-Executive Director | 2.1yrs | Nessun dato | Nessun dato | |
| Independent Non-Executive Director | 1.5yrs | HK$240.00k | Nessun dato |
2.1yrs
Durata media
53yo
Età media
Consiglio di amministrazione esperto: Il consiglio di amministrazione di 3613 non è considerato esperto (durata media del mandato 2 anni), il che suggerisce un nuovo consiglio.